Aveanna Healthcare Holdings Inc.(AVAH)Earnings, Financials & Key RatiosAveanna Healthcare Holdings Inc. (AVAH) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
while the company shows accelerating revenue growth, the high debt-to-equity ratio of 6.26 and erratic cash conversion cycles warrant a cautious approach until fundamental profitability stabilizes.
Aveanna Healthcare Holdings Inc. (AVAH) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Aveanna Healthcare Holdings Inc. (AVAH) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 14, 2026 | $0.18vs $0.13+38.5% | $648Mvs $613M+5.7% |
| Q2 2026 | Mar 19, 2026 | $0.17vs $0.15+10.5% | $662Mvs $643M+3.0% |
| Q4 2025 | Nov 6, 2025 | $0.15vs $0.08+87.5% | $622Mvs $649M-4.2% |
| Q3 2025 | Aug 7, 2025 | $0.18vs $0.04+350.0% | $590Mvs $540M+9.1% |
Recent stock market news and headlines for Aveanna Healthcare Holdings Inc. (AVAH)
AVAH, ARCB, NEXA and IX screen as PEG-based value picks, combining discounted valuations with strong earnings growth metrics and other selection criteria.
Exploring how investors can find highly ranked--Zacks Rank #1 (Strong Buy) or #2 (Buy)--value stocks to buy in July.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
AVAH, NEXA, HPE and LNVGY stand out as GARP stock picks with attractive PEG ratios, value metrics and solid growth potential.
DVA is expanding kidney care through outpatient, home-centered and value-based programs while investing in AI-enabled scheduling.
Key metrics vs top competitors for Aveanna Healthcare Holdings Inc. (AVAH)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $9.60 | $2.09B | 9.14 | 20.19% | 9.25% | 621.89% | — | |
| $39.70 | $1.38B | 47.26 | 36.31% | 2.96% | 8.42% | — | |
| $105.97 | $1.98B | 20.34 | 23.21% | 6.89% | 9.34% | — | |
| $24.39 | $1.67B | 30.11 | 7.08% | 3.67% | 13.6% | — | |
| $170.87 | $9.98B | 29.26 | 18.72% | 6.89% | 16.61% | — | |
| $56.85 | $2.99B | 10.32 | 2.36% | 7.02% | 21.75% | — |
Aveanna Healthcare Holdings Inc. (AVAH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Aveanna Healthcare Holdings Inc. (AVAH) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 15, 2026·SEC
May 14, 2026·SEC
Mar 20, 2026·SEC
Get notified when AVAH posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Aveanna Healthcare Holdings Inc. (AVAH) stock FAQ — growth, dividends, profitability & financials explained
Aveanna Healthcare Holdings Inc. (AVAH) reported $2.52B in revenue for fiscal year 2025. This represents a 101% increase from $1.25B in 2018.
Aveanna Healthcare Holdings Inc. (AVAH) grew revenue by 20.2% over the past year. This is strong growth.
Yes, Aveanna Healthcare Holdings Inc. (AVAH) is profitable, generating $261.5M in net income for fiscal year 2025 (9.2% net margin).
Aveanna Healthcare Holdings Inc. (AVAH) has a return on equity (ROE) of 621.9%. This is excellent, indicating efficient use of shareholder capital.
Aveanna Healthcare Holdings Inc. (AVAH) generated $136.6M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
